Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 4.050
+0.030 (0.75%)
Sep 18, 2026, 4:25 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 1.32 billion as of September 18, 2026. Its market cap has increased by 170.00% in one year.
Market Cap
1.32B
Enterprise Value
896.50M
Revenue
4.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.05
ChartMarket Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 1.32B, a decrease of -76.06%. That is a compound annual growth rate of -19.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.32B | 67.91% |
| Dec 30, 2025 | 787.63M | -20.81% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 3.14B |
| Thor Medical ASA | 2.00B |
| ArcticZymes Technologies ASA | 1.06B |
| Lytix Biopharma ASA | 653.65M |
| Oncoinvent ASA | 604.59M |
| Zelluna ASA | 602.98M |
| SoftOx Solutions AS | 301.29M |
| Arctic Bioscience AS | 75.21M |